Johnson & Johnson launched a new late-stage trial in Britain on Monday to test a two-dose regimen of its experimental Covid-19 vaccine among thousands of volunteers, as the U.S. drugmaker expands its trials by geography and type. The UK arm of the study is aiming to recruit 6,000 participants among […]